Intended for healthcare professionals


FDA to review risks of antidepressants in adults

BMJ 2004; 329 doi: (Published 07 October 2004) Cite this as: BMJ 2004;329:816
  1. Jeanne Lenzer
  1. New York

    The US Food and Drug Administration (FDA) announced last week that it will examine whether antidepressants pose a similar risk of increased suicidal thoughts among adults as they do for children, by reanalysing data for adults.

    “Our first priority with regard to the adult data is to finish our analysis of the adult completed …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription